83 related articles for article (PubMed ID: 7733907)
1. Mutagenesis of human adenosine deaminase to active forms that partially resist inhibition by pentostatin.
Ibrahim MM; Weber IT; Knudsen TB
Biochem Biophys Res Commun; 1995 Apr; 209(2):407-16. PubMed ID: 7733907
[TBL] [Abstract][Full Text] [Related]
2. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
3. Adenosine-mediated killing of cultured epithelial cancer cells.
Barry CP; Lind SE
Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of active site glutamate-217 in mouse adenosine deaminase.
Mohamedali KA; Kurz LC; Rudolph FB
Biochemistry; 1996 Feb; 35(5):1672-80. PubMed ID: 8634299
[TBL] [Abstract][Full Text] [Related]
5. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
[TBL] [Abstract][Full Text] [Related]
6. Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding.
Padua RA; Geiger JD; Delaney SM; Nagy JI
J Neurochem; 1992 Feb; 58(2):421-9. PubMed ID: 1729390
[TBL] [Abstract][Full Text] [Related]
7. 2'-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery.
Padua R; Geiger JD; Dambock S; Nagy JI
J Neurochem; 1990 Apr; 54(4):1169-78. PubMed ID: 2179470
[TBL] [Abstract][Full Text] [Related]
8. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
9. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of histidine 238 in mouse adenosine deaminase: substitution of histidine 238 does not impede hydroxylate formation.
Sideraki V; Wilson DK; Kurz LC; Quiocho FA; Rudolph FB
Biochemistry; 1996 Nov; 35(47):15019-28. PubMed ID: 8942668
[TBL] [Abstract][Full Text] [Related]
11. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG
Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062
[TBL] [Abstract][Full Text] [Related]
12. Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry.
Xu Y; Venton BJ
Phys Chem Chem Phys; 2010 Sep; 12(34):10027-32. PubMed ID: 20577678
[TBL] [Abstract][Full Text] [Related]
13. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
Checkik BE; Perets A; SenGupta S; Fernandes B
J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
[TBL] [Abstract][Full Text] [Related]
14. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
Gandhi V; Chen W; Ayres M; Rhie JK; Madden TL; Newman RA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):85-94. PubMed ID: 12172971
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase 2 from chicken liver: purification, characterization, and N-terminal amino acid sequence.
Iwaki-Egawa S; Namiki C; Watanabe Y
Comp Biochem Physiol B Biochem Mol Biol; 2004 Feb; 137(2):247-54. PubMed ID: 14990221
[TBL] [Abstract][Full Text] [Related]
16. Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase.
Sideraki V; Mohamedali KA; Wilson DK; Chang Z; Kellems RE; Quiocho FA; Rudolph FB
Biochemistry; 1996 Jun; 35(24):7862-72. PubMed ID: 8672487
[TBL] [Abstract][Full Text] [Related]
17. Effect of a chemical modification on the hydrated adenosine intermediate produced by adenosine deaminase and a model reaction for a potential mechanism of action of 5-aminoimidazole ribonucleotide carboxylase.
Groziak MP; Huan ZW; Ding H; Meng Z; Stevens WC; Robinson PD
J Med Chem; 1997 Oct; 40(21):3336-45. PubMed ID: 9341908
[TBL] [Abstract][Full Text] [Related]
18. Complexes of adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity.
Wang Z; Quiocho FA
Biochemistry; 1998 Jun; 37(23):8314-24. PubMed ID: 9622483
[TBL] [Abstract][Full Text] [Related]
19. Pentostatin for the treatment of indolent lymphoproliferative disorders.
Ho AD; Hensel M
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S2-10. PubMed ID: 16549110
[TBL] [Abstract][Full Text] [Related]
20. Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin.
Marrone TJ; Straatsma TP; Briggs JM; Wilson DK; Quiocho FA; McCammon JA
J Med Chem; 1996 Jan; 39(1):277-84. PubMed ID: 8568817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
